| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/16/2004 | CA2516182A1 Expression profiles for breast cancer and methods of use |
| 09/16/2004 | CA2514338A1 Identification of therapeutic compounds |
| 09/15/2004 | EP1457781A1 Simultaneous determination of cell proliferation inhibition activity and toxicity using flow cytometry |
| 09/15/2004 | EP1457780A1 Drugs for ameliorating itch, rough skin or hypersensitive skin or for whitening via inhibition of the production and release of stem cell factor |
| 09/15/2004 | EP1457779A2 Method for determining engine lubricating oil condition |
| 09/15/2004 | EP1457778A1 Method and device for analysing the CO2 content of a borehole fluid |
| 09/15/2004 | EP1457777A1 Method and apparatus for manufacturing a casting piece with a defined surface |
| 09/15/2004 | EP1457776A2 Methods and devices for identifying biopolymers using mass spectroscopy |
| 09/15/2004 | EP1457773A1 Electrode for active oxygen species and sensor using the electrode |
| 09/15/2004 | EP1457772A2 Gas sensor comprising a resistance dependent organic-inorganic intercalated hybrid material and manufacturing method of said sensor |
| 09/15/2004 | EP1457764A1 Device for indicating the residual life of industrial products |
| 09/15/2004 | EP1457572A1 Method of colorimetry and reagent for use therein |
| 09/15/2004 | EP1457571A1 Reporter gene assay method |
| 09/15/2004 | EP1457556A1 Method of quantifying nucleic acid and kit for quantifying nucleic acid |
| 09/15/2004 | EP1457553A1 Plastic plate and plastic plate assembly |
| 09/15/2004 | EP1457500A1 Soluble hybrid prion proteins and their use in the diagnosis, prevention and treatment of transmissible spongiform encephalophathies |
| 09/15/2004 | EP1457499A1 Inhibitors of extracellular Hsp90 |
| 09/15/2004 | EP1457496A1 high density immobilization of nucleic acids |
| 09/15/2004 | EP1457251A1 Separating device, analysis system, separation method and method for manufacture of separating device |
| 09/15/2004 | EP1456800A2 A system and method for consensus-calling with per-base quality values for sample assemblies |
| 09/15/2004 | EP1456670A2 Methods relating to treatment of atherosclerosis |
| 09/15/2004 | EP1456669A2 Method and kit for monitoring recruitment of proteins to the intracellular domain of a receptor in intact cells |
| 09/15/2004 | EP1456668A2 Protein arrays for allelic variants and uses thereof |
| 09/15/2004 | EP1456667A2 Method of mass spectrometry |
| 09/15/2004 | EP1456666A2 Method and apparatus for the determination of glucose |
| 09/15/2004 | EP1456665A2 Breast cancer associated polypeptide |
| 09/15/2004 | EP1456664A1 Use of alpha-tubulin acetylation levels as a biomarker for protein deacetylase inhibitors |
| 09/15/2004 | EP1456663A2 Method for determination of the responsiveness of an individual to mistletoe lectin |
| 09/15/2004 | EP1456662A2 Detection of auto-antibodies from patients suffering from rheumatoid arthritis |
| 09/15/2004 | EP1456661A1 Binding assay device with non-absorbent carrier material |
| 09/15/2004 | EP1456660A1 Methods to view and analyze the results from diffraction-based diagnostics |
| 09/15/2004 | EP1456659A1 Immobilization of binding agents |
| 09/15/2004 | EP1456658A2 Sensor and method for measuring the areal density of magnetic nanoparticles on a micro-array |
| 09/15/2004 | EP1456657A1 Tagged microparticle compositions and methods |
| 09/15/2004 | EP1456653A2 Genes encoding g-protein coupled receptors and methods of use therefor |
| 09/15/2004 | EP1456652A2 Agents that modulate immune cell activation and methods of use thereof |
| 09/15/2004 | EP1456651A2 Self-assembly molecules |
| 09/15/2004 | EP1456650A2 Gfats as modifiers of the p53 pathway and methods of use |
| 09/15/2004 | EP1456649A1 Method for quantitative hemoglobin determination in undiluted unhemolyzed whole blood |
| 09/15/2004 | EP1456648A2 Automated sample preparation methods and devices |
| 09/15/2004 | EP1456647A2 Methods for identifying and validating potential drug targets--- |
| 09/15/2004 | EP1456646A2 Computer system and method for calculating adme properties |
| 09/15/2004 | EP1456645A2 Methods for determining the prognosis for cancer patients using tucan |
| 09/15/2004 | EP1456644A1 Process for determining the odor-inhibiting properties of textile auxiliaries |
| 09/15/2004 | EP1456643A2 Analytical method and apparatus for analysis for surfactants in hydrocarbon distillate fuels |
| 09/15/2004 | EP1456641A2 Detection of odours using insects |
| 09/15/2004 | EP1456636A1 Fet sensor with a specially configured gate electrode for the highly sensitive detection of analytes |
| 09/15/2004 | EP1456635A2 Analytical instruments, biosensors and methods |
| 09/15/2004 | EP1456632A2 Methods for isolating and labeling sample molecules |
| 09/15/2004 | EP1456630A1 Quality and condition monitoring based on spectrum separating measurement |
| 09/15/2004 | EP1456627A2 Procedure for quantitative determination of viral or bacterial particles having a cholesterol-containing envelope |
| 09/15/2004 | EP1456611A1 Device for the capacitive measuring of a fill level |
| 09/15/2004 | EP1456415A2 Fabrication of a high resolution biological molecule detection device with aluminum electrical conductors |
| 09/15/2004 | EP1456413A1 Method of detection of prostate cancer |
| 09/15/2004 | EP1456411A2 Methods of detecting modification of genetic material |
| 09/15/2004 | EP1456410A2 Method for displaying loops from immunoglobulin domains in different contexts |
| 09/15/2004 | EP1456408A2 Susceptibility locus for schizophrenia |
| 09/15/2004 | EP1456405A2 Method and kit for detecting alkaline sphingomyelinase |
| 09/15/2004 | EP1456404A2 A method for determining the biological activity of defibrotide |
| 09/15/2004 | EP1456403A2 Methods of using 48149, a human aminopeptidase family member |
| 09/15/2004 | EP1456402A2 Means for treatment of atherosclerosis |
| 09/15/2004 | EP1456400A2 Modulating insulin receptor signaling through targeting facl |
| 09/15/2004 | EP1456399A1 Total cysteine assay |
| 09/15/2004 | EP1456378A2 Il-17 like molecules and uses thereof |
| 09/15/2004 | EP1456375A1 Screening methods employing fish model assessment of vision |
| 09/15/2004 | EP1456372A2 Emission ratiometric indicators of phosphorylation |
| 09/15/2004 | EP1456371A1 Method for immobilizing a biologic in a polyurethane-hydrogel composition, a composition prepared from the method, and biomedical applications |
| 09/15/2004 | EP1456365A2 Protein modification and maintenance molecules |
| 09/15/2004 | EP1456362A2 Method for the generation of proteins with new enzymatic function |
| 09/15/2004 | EP1456357A2 Pluripotent embryonic-like stem cells derived from teeth and uses thereof |
| 09/15/2004 | EP1456348A1 Saccharomyces-cerevisiae yeast strain with stable integration and expression of the nucleic acid sequence for a heterologous potassium ion channel |
| 09/15/2004 | EP1456346A2 Novel ecdysone receptor/invertebrate retinoid x receptor-based inducible gene expression system |
| 09/15/2004 | EP1456240A2 Target specific screening and its use for identifying target binders |
| 09/15/2004 | EP1456234A2 Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto |
| 09/15/2004 | EP1456227A2 Non-affinity based isotope tagged peptides and methods for using the same |
| 09/15/2004 | EP1456223A2 Rapidly maturing fluorescent proteins and methods for using the same |
| 09/15/2004 | EP1456222A2 Non-human primate fc receptors and methods of use |
| 09/15/2004 | EP1456176A1 Improved compounds for generating chemiluminescence with a peroxidase |
| 09/15/2004 | EP1456130A1 Forming and modifying dielctrically-engineered microparticles |
| 09/15/2004 | EP1456022A2 Nanocrystals |
| 09/15/2004 | EP1455949A1 Centrifugal spectrometer |
| 09/15/2004 | EP1455941A2 Biomolecule handling method and machine using an array dispenser |
| 09/15/2004 | EP1455854A1 Skin/hair equivalent with reconstructed papillae |
| 09/15/2004 | EP1455830A1 Selective anesthetic agents and methods of identifying the same |
| 09/15/2004 | EP1455827A1 Pecam-1 modulation |
| 09/15/2004 | EP1455821A2 Parathyroid hormone antibodies and related methods |
| 09/15/2004 | EP1455765A2 Use of protease-activated receptor-2 inhibitor in the manufacture of a medicament for treating delayed hypersensitivity |
| 09/15/2004 | EP1455700A2 Methods and compositions related to irm compounds and toll-like receptor pathways |
| 09/15/2004 | EP1455652A1 Carrier and specimen-handling tool for use in diagnostic testing |
| 09/15/2004 | EP1455641A1 Method and device for monitoring analyte concentration by optical detection |
| 09/15/2004 | EP1455630A2 Method for cleaning a soiled article |
| 09/15/2004 | EP1455580A2 METHODS AND COMPOSITIONS FOR TREATING HEMATOLOGICAL DISORDERS USING 252, 304, 19870, 14717, 9941, 19310 and 17832 |
| 09/15/2004 | EP1419277A4 Isolation of membrane bound ligand-specific complexes |
| 09/15/2004 | EP1386154A4 Automated methods of detecting receptor activity |
| 09/15/2004 | EP1322325A4 Inhibiting hepatitis c virus processing and replication |
| 09/15/2004 | EP1301783B1 Test member |
| 09/15/2004 | EP1294881B1 Control of metabolism with compositions of the human 2-oxoglutarate carrier |
| 09/15/2004 | EP1282425A4 Crystal structures of p-selectin, p- and e-selectin complexes, and uses thereof |
| 09/15/2004 | EP1246942A4 Ferrofluid based arrays |
| 09/15/2004 | EP1244442B1 Method for detecting nucleotide synthesis inhibitors having fewer side effects |